Catalyst Pharmaceuticals Inc (CPRX)

Cash ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	US$ in thousands	517,553	442,331	375,693	310,411	137,636	120,971	178,787	148,247	298,395	256,065	210,912	178,372	171,445	154,836	135,295	127,328	130,237	117,106	115,052	101,751
Short-term investments	US$ in thousands	—	—	—	—	—	—	—	—	0	0	9,876	19,424	19,821	19,956	19,980	15,971	10,041	10,003	0	5,007
Total current liabilities	US$ in thousands	120,678	105,395	92,318	79,566	76,063	57,806	52,503	56,709	57,588	44,681	22,488	22,938	27,063	20,614	16,135	14,436	22,756	18,232	20,210	17,636
Cash ratio		4.29	4.20	4.07	3.90	1.81	2.09	3.41	2.61	5.18	5.73	9.82	8.62	7.07	8.48	9.62	9.93	6.16	6.97	5.69	6.05

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($517,553K + $—K) ÷ $120,678K
= 4.29

The cash ratio of Catalyst Pharmaceuticals Inc has shown fluctuations over the recorded periods, ranging from as low as 1.81 on December 31, 2023, to as high as 9.93 on March 31, 2021. The cash ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents, providing insights into its liquidity position.

The company maintained a relatively healthy cash ratio above 5 as of December 31, 2024, which indicates that it could cover more than 5 times of its current liabilities with its available cash. The upward trend from March 31, 2023, to March 31, 2024, suggests an improvement in the company's liquidity position. However, the cash ratio decreased from its peak on March 31, 2021, indicating potential changes in the company's cash management or short-term obligations.

It's important for investors and stakeholders to monitor the cash ratio of Catalyst Pharmaceuticals Inc regularly to assess its ability to meet its financial obligations and manage its short-term liquidity effectively. Further analysis and comparison with industry peers may provide a deeper understanding of the company's financial health.